| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |